These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 30939768)
1. Synthesis and Biological Evaluation of RGD⁻Cryptophycin Conjugates for Targeted Drug Delivery. Borbély A; Figueras E; Martins A; Esposito S; Auciello G; Monteagudo E; Di Marco A; Summa V; Cordella P; Perego R; Kemker I; Frese M; Gallinari P; Steinkühler C; Sewald N Pharmaceutics; 2019 Apr; 11(4):. PubMed ID: 30939768 [TBL] [Abstract][Full Text] [Related]
2. Conjugates of Cryptophycin and RGD or Borbély A; Figueras E; Martins A; Bodero L; Raposo Moreira Dias A; López Rivas P; Pina A; Arosio D; Gallinari P; Frese M; Steinkühler C; Gennari C; Piarulli U; Sewald N ChemistryOpen; 2019 Jun; 8(6):737-742. PubMed ID: 31275795 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and Biological Characterization of Monomeric and Tetrameric RGD-Cryptophycin Conjugates. Borbély A; Thoreau F; Figueras E; Kadri M; Coll JL; Boturyn D; Sewald N Chemistry; 2020 Feb; 26(12):2602-2605. PubMed ID: 31943410 [TBL] [Abstract][Full Text] [Related]
4. Octreotide Conjugates for Tumor Targeting and Imaging. Figueras E; Martins A; Borbély A; Le Joncour V; Cordella P; Perego R; Modena D; Pagani P; Esposito S; Auciello G; Frese M; Gallinari P; Laakkonen P; Steinkühler C; Sewald N Pharmaceutics; 2019 May; 11(5):. PubMed ID: 31067748 [TBL] [Abstract][Full Text] [Related]
5. Cryptophycin-55/52 based antibody-drug conjugates: Synthesis, efficacy, and mode of action studies. Lai Q; Wu M; Wang R; Lai W; Tao Y; Lu Y; Wang Y; Yu L; Zhang R; Peng Y; Jiang X; Fu Y; Wang X; Zhang Z; Guo C; Liao W; Zhang Y; Kang T; Chen H; Yao Y; Gou L; Yang J Eur J Med Chem; 2020 Aug; 199():112364. PubMed ID: 32402935 [TBL] [Abstract][Full Text] [Related]
6. Linker Hydrophilicity Modulates the Anticancer Activity of RGD-Cryptophycin Conjugates. Anselmi M; Borbély A; Figueras E; Michalek C; Kemker I; Gentilucci L; Sewald N Chemistry; 2021 Jan; 27(3):1015-1022. PubMed ID: 32955139 [TBL] [Abstract][Full Text] [Related]
7. Development and Biochemical Characterization of Self-Immolative Linker Containing GnRH-III-Drug Conjugates. Schuster S; Juhász É; Halmos G; Neundorf I; Gennari C; Mező G Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563462 [TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo evaluation of Bombesin-MMAE conjugates for targeted tumour therapy. Gomena J; Modena D; Cordella P; Vári B; Ranđelović I; Borbély A; Bottani M; Vári-Mező D; Halmos G; Juhász É; Steinkühler C; Tóvári J; Mező G Eur J Med Chem; 2024 Nov; 277():116767. PubMed ID: 39146832 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and Biological Evaluation of RGD and isoDGR-Monomethyl Auristatin Conjugates Targeting Integrin α Raposo Moreira Dias A; Bodero L; Martins A; Arosio D; Gazzola S; Belvisi L; Pignataro L; Steinkühler C; Dal Corso A; Gennari C; Piarulli U ChemMedChem; 2019 May; 14(9):938-942. PubMed ID: 30840356 [TBL] [Abstract][Full Text] [Related]
10. In vitro pharmacology of cryptophycin 52 (LY355703) in human tumor cell lines. Wagner MM; Paul DC; Shih C; Jordan MA; Wilson L; Williams DC Cancer Chemother Pharmacol; 1999; 43(2):115-25. PubMed ID: 9923816 [TBL] [Abstract][Full Text] [Related]
11. RGD Peptidomimetic MMAE-Conjugate Addressing Integrin αVβ3-Expressing Cells with High Targeting Index. Paulus J; Nachtigall B; Meyer P; Sewald N Chemistry; 2023 Feb; 29(12):e202203476. PubMed ID: 36454662 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of RGD peptidomimetic-paclitaxel conjugates bearing lysosomally cleavable linkers. Dal Corso A; Caruso M; Belvisi L; Arosio D; Piarulli U; Albanese C; Gasparri F; Marsiglio A; Sola F; Troiani S; Valsasina B; Pignataro L; Donati D; Gennari C Chemistry; 2015 Apr; 21(18):6921-9. PubMed ID: 25784522 [TBL] [Abstract][Full Text] [Related]
13. The cryptophycins as potent payloads for antibody drug conjugates. Verma VA; Pillow TH; DePalatis L; Li G; Phillips GL; Polson AG; Raab HE; Spencer S; Zheng B Bioorg Med Chem Lett; 2015 Feb; 25(4):864-8. PubMed ID: 25613677 [TBL] [Abstract][Full Text] [Related]
14. Potent antitumor activity of anti-HER2 antibody-topoisomerase I inhibitor conjugate based on self-immolative dendritic dimeric-linker. Liubomirski Y; Tiram G; Scomparin A; Gnaim S; Das S; Gholap S; Ge L; Yeini E; Shelef O; Zauberman A; Berger N; Kalimi D; Toister-Achituv M; Schröter C; Dickgiesser S; Tonillo J; Shan M; Deutsch C; Sweeney-Lasch S; Shabat D; Satchi-Fainaro R J Control Release; 2024 Mar; 367():148-157. PubMed ID: 38228272 [TBL] [Abstract][Full Text] [Related]
15. Improved Methodology for the Synthesis of a Cathepsin B Cleavable Dipeptide Linker, Widely Used in Antibody-Drug Conjugate Research. Mondal D; Ford J; Pinney KG Tetrahedron Lett; 2018 Oct; 59(40):3594-3599. PubMed ID: 31156276 [TBL] [Abstract][Full Text] [Related]
16. Neutrophil elastase as a versatile cleavage enzyme for activation of αvβ3 integrin-targeted small molecule drug conjugates with different payload classes in the tumor microenvironment. Rebstock AS; Wiedmann M; Stelte-Ludwig B; Wong H; Johnson AJ; Izumi R; Hamdy A; Lerchen HG Front Pharmacol; 2024; 15():1358393. PubMed ID: 38495100 [No Abstract] [Full Text] [Related]
17. Dual-drug RGD conjugates provide enhanced cytotoxicity to melanoma and non-small lung cancer cells. Gilad Y; Noy E; Senderowitz H; Albeck A; Firer MA; Gellerman G Biopolymers; 2016 Mar; 106(2):160-171. PubMed ID: 26715008 [TBL] [Abstract][Full Text] [Related]